Voloridge Investment Management’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-454,125
Closed -$11.1M 1146
2025
Q1
$11.1M Sell
454,125
-76,197
-14% -$1.96M 0.04% 541
2024
Q4
$12.7M Buy
+530,322
New +$16.8M 0.04% 507
2023
Q3
Sell
-24,260
Closed -$2.65M 1363
2023
Q2
$2.65M Sell
24,260
-185,147
-88% -$17.6M 0.01% 898
2023
Q1
$17.4M Buy
209,407
+204,168
+3,897% +$19.2M 0.09% 323
2022
Q4
$539K Sell
5,239
-6,231
-54% -$718K ﹤0.01% 1255
2022
Q3
$1.22M Buy
+11,470
New +$1.26M 0.01% 1106
2021
Q3
Sell
-47,352
Closed -$4.59M 1623
2021
Q2
$4.59M Buy
+47,352
New +$4.11M 0.03% 676
2020
Q2
Sell
-13,973
Closed -$808K 1237
2020
Q1
$808K Buy
+13,973
New +$956K 0.02% 571
2019
Q4
Sell
-10,602
Closed -$610K 1066
2019
Q3
$610K Buy
+10,602
New +$587K 0.01% 750
2019
Q2
Sell
-27,817
Closed -$1.31M 739
2019
Q1
$1.31M Buy
+27,817
New +$1.54M 0.04% 395
2018
Q2
Sell
-21,101
Closed -$1.2M 401
2018
Q1
$1.2M Buy
21,101
+13,394
+174% +$728K 0.03% 339
2017
Q4
$380K Buy
+7,707
New +$351K 0.01% 437

Other funds holding AMN

Voloridge Investment Management's AMN Position: Q2 2025 in Review

Voloridge Investment Management sold out of AMN Healthcare (AMN) in Q2 2025, closing a stake of 454,125 shares — an estimated $11.1M sold.

Voloridge Investment Management first reported a position in AMN in Q4 2017 and held it in 12 quarters. The position peaked at $17.4M in Q1 2023. 248 funds tracked by Wall St. Rank hold AMN as of Q2 2025.

  • Voloridge Investment Management reported no remaining AMN Healthcare position as of Q2 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 454,125 AMN Healthcare shares in Q2 2025, an estimated $11.1M.
  • Voloridge Investment Management first reported a position in AMN Healthcare in Q4 2017 and held it in 12 quarters.
  • Voloridge Investment Management's AMN Healthcare position peaked at $17.4M in Q1 2023.
  • 248 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2025.

Based on Voloridge Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.